← Back to Search

Behavioral Intervention

BC-Navi for Quality of Life

N/A
Waitlist Available
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with non-metastatic breast cancer (stages I-III)
An order placed for a post-operative chemotherapy cycle by a NM clinician
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial aims to use a new website/app called BC-Navigate to help guide women through breast cancer treatment. The study will focus on Black, African American, and other women of color to improve their

Who is the study for?
This trial is for women of color with breast cancer, focusing on Black and African American individuals. Participants should be receiving care at Northwestern's breast cancer program and willing to use the BC-Navigate website/app for guidance during treatment.Check my eligibility
What is being tested?
The study tests a patient navigation-and-coaching program provided through the BC-Navigate app, aiming to improve knowledge, self-advocacy, and timely initiation of adjuvant therapy among participants.See study design
What are the potential side effects?
Since this intervention involves educational support rather than medical treatment, traditional side effects are not applicable. However, users may experience stress or anxiety related to navigating their care.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My breast cancer is in stages I-III and has not spread to distant parts of my body.
Select...
A specialist has scheduled me for chemotherapy after surgery.
Select...
I am 18 years old or older.
Select...
I have not started any recommended chemotherapy after surgery.
Select...
I have completed surgery for breast cancer.
Select...
I have been diagnosed with breast cancer for the first time.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of BC-Navi
Demand of BC-Navi: Recruitment Rate
Demand of BC-Navi: Rentention Rate
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: BC-NaviExperimental Treatment1 Intervention
Apply TCI's patient navigation-and-coaching program and its website/mobile app (Breast Cancer-Navigate) platform to improve timely initiation to patient adjuvant chemotherapy treatment among diverse breast cancer patients.

Find a Location

Who is running the clinical trial?

The Chrysalis InitiativeUNKNOWN
Northwestern UniversityLead Sponsor
1,585 Previous Clinical Trials
917,081 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available positions for patients to participate in this clinical trial?

"As per the information available on clinicaltrials.gov, recruitment for this particular trial is currently closed. It was initially listed on March 1st, 2024, with the latest update made on February 14th, 2024. Despite this trial's closure to new participants, there are a substantial number of 2930 other trials actively seeking candidates at present."

Answered by AI
~100 spots leftby Mar 2025